Press Releases COGNOA PRESS RELEASES Cognoa Named One Of Fierce Medtech’s 2022 Fierce 15 Read More » March 7, 2022 Cognoa Appoints Seasoned Financial Executive, Tony Rimac, as Chief Financial Officer Read More » September 30, 2021 Cognoa Receives FDA Marketing Authorization for First-of-its-kind Autism Diagnosis Aid Read More » June 2, 2021 Cognoa Appoints Industry Veteran Eric B. Mosbrooker as Chief Operations Officer Read More » January 13, 2021 Cognoa Seeks FDA Clearance for Breakthrough Digital Autism Diagnostic Device After Successful Pivotal Study Read More » September 22, 2020 Cognoa Appoints Industry Leader David Happel as New Chief Executive Officer Read More » March 23, 2020 « Previous Page1 Page2 Page3 Page4 Page5 Page6 Next » For media inquiries, please contact media@cognoa.com Learn about our efforts to advance pediatric behavioral healthcare. Learn More
Cognoa Appoints Seasoned Financial Executive, Tony Rimac, as Chief Financial Officer Read More » September 30, 2021
Cognoa Receives FDA Marketing Authorization for First-of-its-kind Autism Diagnosis Aid Read More » June 2, 2021
Cognoa Appoints Industry Veteran Eric B. Mosbrooker as Chief Operations Officer Read More » January 13, 2021
Cognoa Seeks FDA Clearance for Breakthrough Digital Autism Diagnostic Device After Successful Pivotal Study Read More » September 22, 2020
Cognoa Appoints Industry Leader David Happel as New Chief Executive Officer Read More » March 23, 2020
